The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Extension of Share Buy-back Programme

23 Jan 2018 14:43

RNS Number : 6987C
FastForward Innovations Limited
23 January 2018
 

23 January 2018

 

 

FastForward Innovations Ltd

("FastForward" or the "Company")

Extension of Share Buy-Back Programme

Compliance with Market Abuse Regulation

FastForward Innovations Limited (AIM: FFWD) (the "Company") today announces that the share buy-back programme announced by the Company on 20 November 2017 has been extended until 28 February 2018 (the "Extended Period").

As at 19 January 2018, the Company had redeemed in aggregate 790,000 shares at an average price of £0.16.

During the Extended Period the Company has approved the redemption of up to a maximum of 3,400,000 further shares (the "Extended Buy-Back Programme"). The Extended Buy-Back Programme will be funded from existing cash resources and is being undertaken given the Directors' belief that the current market price, particularly given the recent listing of Nuuvera Inc. and positive developments across the Company's portfolio of investments in 2017,. significantly undervalues the underlying value of the Company's investment portfolio.

Any purchase of Ordinary Shares made in relation to this announcement will be carried out on the open market during the period commencing on 22 January and ending not later than 28 February 2018.

The Extended Buy-Back Programme shall be executed in accordance with the Company's general authority to make market purchases of Ordinary Shares as approved by Shareholders on 16 September 2016 and those provisions of Market Abuse Regulation 596/2014/EU dealing with buy-back programmes including in particular in relation to trading restrictions regarding time and volume, disclosure and reporting obligations, and price conditions set out under Market Abuse Regulation 596/2014/EU.

The shares purchased by the Company will be held in treasury pending cancellation. Optiva Securities Limited is the Company's broker in relation to the Programme:

Name of Programme

2017 - 2018 Share Buy-Back Programme

Purpose of the Programme

To reduce the capital of the issuer

Duration of the Programme

20 November 2017 to 28 February 2018

Maximum amount allocated to the Programme

US$900,000 (approximately £652,646)

Maximum number of shares to be acquired

Up to 3,400,000 ordinary shares

Maximum price

 

The higher of:

a) the price of the last independent trade; and

b) the highest current independent purchase bid on the trading venue where the purchase is carried out.

Maximum size of purchase on any trading day

25% of the average daily volume of the shares on the trading venue on which the purchase is carried out, such average daily volume calculated over the 20 trading days preceding the date of purchase

 

 

FastForward Innovations Limited

info@fstfwd.co

Sue Saunders / Ian Burns

 

Beaumont Cornish Limited (Nomad) Tel: +44 (0) 207 628 3396

James Biddle / Roland Cornish

 

Optiva Securities Limited (Broker) Tel: +44 (0) 203 411 1881

Ed McDermott

CAUTIONARY STATEMENT

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of Fast Forward Innovations Ltd. There can be no assurance that such statements will prove to be accurate, achievable or recognizable in the near term.

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Fast Forward Innovations assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBSGDBBSDBGIX
Date   Source Headline
17th Nov 202010:30 amRNSHolding(s) in Company
12th Nov 20207:00 amRNSInvestee Company Update: Portage Biotech Inc.
5th Nov 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
16th Oct 20209:00 amRNSInvestee Company Update: EMMAC Life Sciences
13th Oct 20207:00 amRNSPlacing and Issue of Equity
23rd Sep 20201:30 pmRNSInvestee Company Update: Yooma Corp.
23rd Sep 20207:00 amRNSHolding(s) in Company
22nd Sep 20207:00 amRNSChange of Broker
17th Sep 20203:45 pmRNSResult of AGM
16th Sep 20204:00 pmRNSInvestee Company Update: Juvenescence Limited
8th Sep 20204:00 pmRNSUpdated Key Information Document
27th Aug 20204:30 pmRNSInvestee Company Update: Factom Inc.
26th Aug 20207:30 amRNSNotice of AGM
26th Aug 20207:00 amRNSFinal Results
25th Aug 20202:30 pmRNSInvestee Company Update: Portage Biotech Inc.
24th Aug 20203:15 pmRNSInvestee Company Update: Leap Gaming
18th Aug 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
5th Aug 20207:00 amRNSInvestee Company Update: Leap Gaming
30th Jul 20208:52 amRNSInvestee Company Update: Factom Inc.
30th Jul 20207:45 amRNSInvestee Company Update: Portage Biotech Inc.
28th Jul 202011:55 amRNSInvestee Company Update: EMMAC Life Sciences
22nd Jul 20201:39 pmRNSInvestee Company Update: EMMAC Life Sciences
14th Jul 202010:15 amRNSInvestee Company Update: Yooma Corp.
13th Jul 20205:01 pmRNSResult of Extraordinary General Meeting
9th Jul 20207:00 amRNSInvestee Company Update: Factom Inc.
6th Jul 202010:31 amRNSInvestee Company Update: Leap Gaming
26th Jun 202012:30 pmRNSNotice of EGM & Proposed Updated Investing Policy
22nd Jun 20207:45 amRNSInvestee Company Update: Leap Gaming
22nd Jun 20207:30 amRNSInvestee Company Update: Leap Gaming
22nd Jun 20207:00 amRNSInvestee Company Update: Factom Inc.
17th Jun 20201:00 pmRNSInvestee Company Update: Portage Biotech Inc.
2nd Jun 20209:30 amRNSInvestee Company Update: Juvenescence Limited
26th May 20207:00 amRNSInvestee Company Update: Portage Biotech Inc
26th May 20207:00 amRNSInvestee Company Update: EMMAC Life Sciences
21st May 20207:00 amRNSInvestee Company Update: Leap Gaming
19th May 20207:30 amRNSInvestee Company Update: EMMAC Life Sciences
18th May 20207:00 amRNSInvestee Company Update re Yooma and Board Changes
12th May 202010:15 amRNSInvestee Company Update: Portage Biotech Inc.
6th May 202012:30 pmRNSInvestee Company Update: Portage Biotech Inc.
23rd Apr 20203:15 pmRNSInvestee Company Update: Entertainment Direct Asia
23rd Apr 20207:00 amRNSHolding(s) in Company
16th Apr 20204:15 pmRNSInvestee Company Update: Portage Biotech Inc.
16th Apr 20202:00 pmRNSInvestee Company Update: Portage Biotech Inc.
14th Apr 20207:00 amRNSCorporate Update
2nd Apr 20207:00 amRNSInvestee Company Update: Factom Inc.
1st Apr 20207:00 amRNSInvestee Company Update: Leap Gaming
31st Mar 20201:15 pmRNSInvestee Company Update: EMMAC Life Sciences
20th Mar 20205:04 pmRNSInvestee Company Update: Entertainment Direct Asia
19th Mar 20202:30 pmRNSInvestee Company Update: Factom Inc.
17th Mar 20207:00 amRNSInvestee Company Update: Portage Biotech Inc.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.